Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 10-2019 | 10-2018 | 10-2017 | 10-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,938 | 1,352 | 1,352 | 2,010 | 3,922 |
| Marketable Securities | N/A | 1,510 | 780 | 768 | 528 |
| Receivables | 377 | 553 | 367 | 491 | 175 |
| TOTAL | $3,426 | $4,001 | $2,577 | $3,300 | $4,676 |
| Non-Current Assets | |||||
| PPE Net | 151 | 189 | 225 | 182 | 20 |
| Intangibles | 682 | 0 | 0 | 0 | 0 |
| TOTAL | $833 | $189 | $225 | $182 | $20 |
| Total Assets | $4,259 | $4,190 | $2,802 | $3,482 | $4,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 653 | 517 | 265 | 355 | 144 |
| TOTAL | $653 | $517 | $265 | $689 | $638 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 335 | 494 |
| Other Non-Current Liabilities | 523 | 0 | 0 | 0 | 0 |
| TOTAL | $523 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,176 | $517 | $265 | $689 | $638 |
| Shareholders' Equity | |||||
| Common Shares | 33,208 | 31,078 | 26,337 | 25,760 | 24,818 |
| Retained earnings | -35,546 | -31,949 | -29,911 | -26,616 | -24,253 |
| Other shareholders' equity | 1,153 | 832 | 2,787 | 760 | 749 |
| TOTAL | $3,083 | $3,673 | $2,536 | $2,793 | $4,057 |
| Total Liabilities And Equity | $4,259 | $4,190 | $2,802 | $3,482 | $4,696 |